A majority of patients feel lay summaries for clinical trials are very important and won’t participate in future trials if not provided with one...
Featured content
A Summarized Report of the Virtual MedTech EU MDR Exchange...
Session summaries from EUMDR exchange conference 2021.
Latest Content
HEOR in 2022: The Importance of Data Visualization, RWD, and...
Effectively communicating data in the pharmaceutical and medical community is vital to payer engagement. Learn how Cactus Life Sciences can help!
Bite-sized Content Helps Avoid User Fatigue – How Can Pharma Use...
Today's readers tend to avoid long pharma content and medical jargon. If you want to engage them, keep the content simple, bite-sized, and actionable.
Why the Healthcare Industry MUST Care About the Caregiver
Caregivers are vital in the treatment of a patient, whether at home or in a hospital or hospice. Ensuring that they're educated, listened to, and...
Understanding Patient Centricity, Progress Made, and Barriers...
Cactus Life Sciences conducted a survey of pharma/biotech and associated industry professionals to gather their opinions on what patient centricity...
Medical Device Manufacturing: Risk-Based QMS Alignment for EU-MDR
The latest EU-MDR guidelines are a step in the right direction, moving from a focus on the pre-approval stage of medical device manufacturing toward...
What Makes Stakeholders Trust Pharma-Generated Scientific...
While diverse pharma stakeholders are now consuming scientific content digitally more than ever before, the content itself is still largely designed...